Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy R Chapman

Showing results (31-40 of 200) with videos related to

Pageof 20
Sort By:
Kidney International|August 20, 2023
Histology versus molecular surveillance: claims and evidenceBrian J Nankivell, Jeremy R Chapman
Transplantation|February 23, 2016
Care of Transplant Recipients in Primary PracticeDamien P Brown, Jeremy R Chapman
Transplantation|July 7, 2015
President's Address: International Liver Transplantation SocietyJeremy R Chapman, Elizabeth A Pomfret
Transplantation|January 4, 2022
Simple Vaccination Is not Enough for the Transplant RecipientJeremy R Chapman, Stephen J Wigmore
Transplantation|March 15, 2006
Chronic allograft nephropathy: current concepts and future directionsBrian J Nankivell, Jeremy R Chapman
Current Opinion in Organ Transplantation|December 9, 2008
Individualization of immunosuppression: concepts and rationaleMoses D Wavamunno, Jeremy R Chapman
Kidney International|April 17, 2016
Buyer beware transplantationJeremy R Chapman, Francis L Delmonico
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 15, 2013
Can the risk of skin cancer after transplantation be reduced by mTOR Inhibitors?Robert P Carroll, Jeremy R Chapman
Transplantation|June 6, 2013
Are nonesterified fatty acids protective in chronic allograft nephropathy?Jeremy R Chapman, Gopala K Rangan
Nephrology (Carlton, Vic.)|December 16, 2005
Sirolimus: its role in nephrologyVincent Ws Lee, Jeremy R Chapman
Pageof 20

Showing results (31-40 of 200) with videos related to

Sort By:
Pageof 20
Kidney International|August 20, 2023
Histology versus molecular surveillance: claims and evidenceBrian J Nankivell, Jeremy R Chapman
Transplantation|February 23, 2016
Care of Transplant Recipients in Primary PracticeDamien P Brown, Jeremy R Chapman
Transplantation|July 7, 2015
President's Address: International Liver Transplantation SocietyJeremy R Chapman, Elizabeth A Pomfret
Transplantation|January 4, 2022
Simple Vaccination Is not Enough for the Transplant RecipientJeremy R Chapman, Stephen J Wigmore
Transplantation|March 15, 2006
Chronic allograft nephropathy: current concepts and future directionsBrian J Nankivell, Jeremy R Chapman
Current Opinion in Organ Transplantation|December 9, 2008
Individualization of immunosuppression: concepts and rationaleMoses D Wavamunno, Jeremy R Chapman
Kidney International|April 17, 2016
Buyer beware transplantationJeremy R Chapman, Francis L Delmonico
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 15, 2013
Can the risk of skin cancer after transplantation be reduced by mTOR Inhibitors?Robert P Carroll, Jeremy R Chapman
Transplantation|June 6, 2013
Are nonesterified fatty acids protective in chronic allograft nephropathy?Jeremy R Chapman, Gopala K Rangan
Nephrology (Carlton, Vic.)|December 16, 2005
Sirolimus: its role in nephrologyVincent Ws Lee, Jeremy R Chapman
Pageof 20